In NSCLC, inhibition of BRD4 enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis and restrains tumor growth by downregulating eukaryotic translation initiation factor 4E (eIF4E) [18, 19]. This evidence concerns the gene BRD4 and neoplasm.